Biogen, Inc. (BIIB)
219.88
-2.94
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
219.10
-0.78
(-0.35%)
After-Hours: 20:00
Biogen Profit Margin (Quarterly) : 3.72% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.72% |
| March 31, 2026 | 13.29% |
| December 31, 2025 | -2.24% |
| September 30, 2025 | 19.00% |
| June 30, 2025 | 24.78% |
| March 31, 2025 | 10.30% |
| December 31, 2024 | 11.41% |
| September 30, 2024 | 16.35% |
| June 30, 2024 | 24.80% |
| March 31, 2024 | 17.88% |
| December 31, 2023 | 10.82% |
| September 30, 2023 | -2.80% |
| June 30, 2023 | 25.24% |
| March 31, 2023 | 16.63% |
| December 31, 2022 | 22.04% |
| September 30, 2022 | 49.49% |
| June 30, 2022 | 44.01% |
| March 31, 2022 | 9.20% |
| December 31, 2021 | -0.79% |
| September 30, 2021 | 12.01% |
| June 30, 2021 | 39.03% |
| March 31, 2021 | 16.22% |
| December 31, 2020 | 38.42% |
| September 30, 2020 | 22.57% |
| June 30, 2020 | 47.22% |
| Date | Value |
|---|---|
| March 31, 2020 | 44.12% |
| December 31, 2019 | 44.21% |
| September 30, 2019 | 48.75% |
| June 30, 2019 | 46.60% |
| March 31, 2019 | 45.73% |
| December 31, 2018 | 30.01% |
| September 30, 2018 | 46.71% |
| June 30, 2018 | 30.50% |
| March 31, 2018 | 41.60% |
| December 31, 2017 | -5.54% |
| September 30, 2017 | 44.24% |
| June 30, 2017 | 31.63% |
| March 31, 2017 | 30.14% |
| December 31, 2016 | 22.61% |
| September 30, 2016 | 38.73% |
| June 30, 2016 | 40.88% |
| March 31, 2016 | 40.29% |
| December 31, 2015 | 29.75% |
| September 30, 2015 | 42.23% |
| June 30, 2015 | 41.51% |
| March 31, 2015 | 37.11% |
| December 31, 2014 | 33.60% |
| September 30, 2014 | 38.25% |
| June 30, 2014 | 33.76% |
| March 31, 2014 | 25.78% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -42.79% |
| AbbVie, Inc. | 21.21% |
| Gilead Sciences, Inc. | -134.2% |
| Regeneron Pharmaceuticals, Inc. | 30.23% |
| Amgen, Inc. | 23.59% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.56% |
| Return on Assets | 2.81% |
| Return on Invested Capital | 3.30% |
| Gross Profit Margin (Quarterly) | 61.37% |
| Operating Margin (Quarterly) | 16.71% |
| Return on Net Operating Assets | 3.39% |